Treatments
880 articles
World Pancreatic Cancer Coalition Members Demand Better on World Pancreatic Cancer Day
World Pancreatic Cancer Coalition members come together on World Pancreatic Cancer Day to demand better for patients, treatments, early detection, research.
Let’s Win and the Lustgarten Foundation Demand Better for World Pancreatic Cancer Day
Cindy Gavin of Let’s Win and Kerri Kaplan of the Lustgarten Foundation demand better for treatments and research on World Pancreatic Cancer Day.
Let’s Win! Pancreatic Cancer Survivors Series—Year Three
Let’s Win kicks off Year Three of its Survivors Series of videos. The 2020 videos will feature patients with genetic mutations and more researchers.
Let’s Learn Webinar on Symptoms on March 25th
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our Symptoms webinar to learn more!
Hope For All Stages
The doctors and researchers at the Penn Pancreatic Cancer Research Center examine different aspects of pancreatic cancer to find better treatments.
Let’s Win Launches Online Video Series Featuring Long-Term Pancreatic Cancer Survivors
Meet long-term survivors of pancreatic cancers, in our new Survivors Video Series. The introductory video was launched in January at a cancer symposium.
mRNA Vaccine Shows Promising Results
Dr. Vinod Balachandran is testing an mRNA vaccine for pancreatic cancer using the same technology as COVID vaccines.
Artificial Intelligence and Early Detection of Pancreatic Cancer
How can AI be used in the early detection of pancreatic cancer? Dr. Michael Rosenthal reviews the current state of the field.
NALIRIFOX Shows Promise in Early Studies
Dr. Zev Wainberg describes the new combination NALIRIFOX, being tested in the NAPOLI-3 clinical trial for advanced pancreatic cancer patients.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
Multicenter Trial Focuses on Neoadjuvant Treatment for Borderline Resectable and Locally Advanced Disease
Dr. David Ryan outlines a new trial for pre-surgical pancreatic cancer treatment combining a blood pressure drug, immunotherapy, standard care and SBRT.
A Simple Blood Test for Early Detection of Eight Cancers Shows Promise
Dr. Anne Marie Lennon explains the CancerSEEK blood test, a liquid biopsy in clinical trials for early detection of eight cancers, including pancreatic.
An Immunotherapy Game Changer
Immunotherapy with Keytruda (pembrolizumab) is approved for use in cancer patients with certain genetic defects in their tumors.
Understanding a Family’s Risk for Pancreatic Cancer
A tumor registry studies the genetics of pancreatic cancer to determine risk factors for families.
Why You Need This Simple Blood Test at Diagnosis
An important factor in determining which treatment to use for pancreatic cancer patients is measuring the level of tumor marker CA-19-9. Learn more here.